CLASS III Drug recall · Reported 3 Nov 2021 · FDA Enforcement Report

AllerClear D-24 hr, (Loratadine and Pseudoephedrine Sulfate recalled

SUN Pharmaceutical Industries is recalling AllerClear D-24 hr, (Loratadine and Pseudoephedrine Sulfate, Extended-Release Tablets, distributed nationwide in the US. The recall was initiated on 12 Oct 2021 and the FDA has classified it as Class III.

Check your package

Lot, batch or date codesAC09723, Exo, Date 11/2022
NDC63981-724
Quantity recalled46,584 blister packs

Check the lot number on your package against the affected lots. If it matches, contact the pharmacy that dispensed it or your prescriber before stopping any medication.

Recall details

Recall number
D-0069-2022
FDA event ID
88806
Recalling firm
SUN Pharmaceutical Industries, Princeton, NJ
Manufacturer
Kirkland-COSTCO WHOLESALE COMPANY
Classification
Class III
Status
Terminated
Recall initiated
12 Oct 2021
FDA classified
26 Oct 2021
Reported
3 Nov 2021
Type
Voluntary: Firm initiated
Customers notified by
Letter
Reason category
Other Reasons

Timeline

12 Oct 2021Recall initiated by company
26 Oct 2021Classified by FDA+14 days
3 Nov 2021Published in enforcement report+8 days

Companies usually start a recall weeks before the FDA classifies and publishes it; the gap above is that lag.

Reason for recall

Failed Moisture Limits

Product as listed by the FDA

AllerClear D-24 hr, (Loratadine and Pseudoephedrine Sulfate, Extended-Release Tablets, USP 10/240mg), 15-count blister packs, Manufactured by: Ohm Laboratories Inc., 1385 Livingston Avenue, North Brunswick, NJ 08902, NDC 63981-724-15

Where it was distributed

Nationwide within the United States

Nationwide

Questions about this recall

Why was it recalled?

Failed Moisture Limits

Which lots are affected?

AC09723, Exo, Date 11/2022

Where was it sold?

Nationwide within the United States

What should I do if I have it?

Check the lot number on your package against the affected lots. If it matches, contact the pharmacy that dispensed it or your prescriber before stopping any medication.

What does Class III mean?

Class III recalls are for products unlikely to cause any adverse health consequence, usually labelling or quality issues.

Read the official FDA notice · Source record retrieved 26 Sep 2026. The FDA describes openFDA data as unvalidated; the official notice takes precedence. This page reports the record and gives no medical advice.

Other products in this recall event

1 other product · FDA event 88806
ReportedClassRecallCompanyReasonWhere
CLASS IIILoratadine-D Extended-Release Tablets (Loratadine recalledLoratadine And Pseudoephedrine SulfateSUN Pharmaceutical IndustriesOtherNationwide

More recalls from SUN Pharmaceutical Industries

All 138

Other Loratadine recalls

All 7
ReportedClassRecallCompanyReasonWhere
DrugCLASS IIILoratadine-D Extended-Release Tablets (Loratadine recalledLoratadine And Pseudoephedrine SulfateSUN Pharmaceutical IndustriesOtherNationwide
DrugCLASS IIChildren's Loratadine Oral Solution USP, 5 mg recalledChildrens LoratadineCardinal HealthManufacturing (CGMP) DeviationsFL, GA, SC
DrugCLASS IIIOhm Loratadine Orally Disintegrating Tablets recalledAllergy ReliefOhm LaboratoriesPotency & AssayNationwide
DrugCLASS IINon-Drowsy 24 Hour Formula Allergy Relief recalled by Ohm LaboratoriesLoratadine And Pseudoephedrine SulfateOhm LaboratoriesOther4 states
DrugCLASS IILoratadine Tablet, 10 mg recalled by Aidapak ServicesAidapak ServicesLabeling Errors4 states